NDC 43376-322

FINTEPLA

Fenfluramine

FINTEPLA is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Zogenix, Inc.. The primary component is Fenfluramine.

Product ID43376-322_1b988653-f85f-410d-b340-055aa0e52772
NDC43376-322
Product TypeHuman Prescription Drug
Proprietary NameFINTEPLA
Generic NameFenfluramine
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date2020-07-15
Marketing CategoryNDA / NDA
Application NumberNDA212102
Labeler NameZogenix, Inc.
Substance NameFENFLURAMINE
Active Ingredient Strength2 mg/mL
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 43376-322-30

1 BOTTLE, PLASTIC in 1 CARTON (43376-322-30) > 30 mL in 1 BOTTLE, PLASTIC
Marketing Start Date2020-07-15
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [FINTEPLA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
FINTEPLA
FINTEPLA
88284913 not registered Live/Pending
ZOGENIX INTERNATIONAL LIMITED
2019-01-31
FINTEPLA
FINTEPLA
87687367 not registered Dead/Abandoned
ZOGENIX INTERNATIONAL LIMITED
2017-11-16
FINTEPLA
FINTEPLA
86949118 5443859 Live/Registered
Zogenix International Limited
2016-03-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.